<?xml version="1.0" encoding="UTF-8"?>
<p>Serum and CSF samples were obtained from the National Health Laboratory Service, Thswane Academic Division, Thswane, South Africa, which serves public sector hospitals in northern South Africa. To select samples for testing, we reviewed laboratory submission requests for patients with clinical conditions consistent with WNV infection: fever, headache, rash, or neurologic signs (
 <xref ref-type="bibr" rid="R7">7</xref>,
 <xref ref-type="bibr" rid="R8">8</xref>). A total of 206 patient samples (15 CSF and 191 serum) were selected. During September 2008â€“May 2009, we screened samples for the presence of WNV by using real-time, reverse-transcription PCR (rRT-PCR) (
 <xref ref-type="bibr" rid="R9">9</xref>), virus neutralization assay, and IgM ELISA.
</p>
